JAMA Clinical Reviews JAMA Editors’ Choice 2024: Clinical Reviews Podcasts
27 snips
Jan 2, 2025 Robert Kushner, a renowned author and professor at Northwestern University's Feinberg School of Medicine, dives into the latest advancements in obesity treatment. He discusses new FDA-approved medications, such as semaglutide and terzepatide, highlighting their effectiveness and side effects. Kushner emphasizes the importance of treating obesity as a chronic disease, the potential implications of stopping medication, and the need for gradual dose adjustments. This insightful conversation sheds light on the evolving landscape of obesity management.
AI Snips
Chapters
Transcript
Episode notes
Managing Side Effects of Obesity Medications
- Slowly increase medication dosage to minimize gastrointestinal side effects like nausea and diarrhea.
- Counsel patients on a healthy diet with smaller, low-fat meals and hydration.
Long-Term Use of Obesity Medications
- Suddenly stopping anti-obesity medications leads to significant weight regain.
- Research explores alternative strategies like intermittent use or dose reduction.
Long-Term Obesity Management
- Consider obesity a chronic disease requiring long-term treatment like diabetes or hypertension.
- Continue medication if tolerated and effective, but explore alternative medications or strategies.